Skip to main content
OpenTrials
Completed

NCT Number: NCT04809727

Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

Supracervical hysterectomy is widely common and had many complications either immediate or delayed. In these patients bleeding, infection, chronic pelvic pain are common. In these patients cervical biopsy was done and histopathological examinations were done to evaluate the pathology in these patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

CIN Cancer of Cervix Cervicitis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Cervicitis Uterine Diseases Uterine Neoplasms

Age range

40 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ayman Shehata Dawood

Tanta, Gharbia Governorate, 31111, Egypt

About this study

  • Study design and settings: Cross sectional descriptive studies conducted from December 2017 till January 2021.
  • Patients: 80 patients with supracervical hysterectomy recruited at Tanta University Hospital, gynecology clinics will be recruited according inclusion and exclusion criteria. Inclusion criteria include all symptomatizing patients following supracervical hysterectomy, of any age, of any complaints. The exclusion criteria were patients with total hysterectomy, hysterectomies for malignant indications, and refusal to participate.
  • Methods: All patients' demographic data, history, indication of hysterectomy, duration since operation, postoperative complications and their main complaint.

Intervention: under general anesthesia cervical biopsy (4 quadrants) were taken from all patients and was sent for histopathological examinations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all symptomatizing patients following supracervical hysterectomy,

Exclusion criteria

  • with total hysterectomy,
  • hysterectomies for malignant indications,
  • refusal to participate.

Treatment and study plan

Cervical Biopsy

Procedure

4 quadrant biopsy

Primary outcomes

  1. Detection of cervical neoplasia or cancer incidence

    Time frame: 1 year

    Detection of number of cases diagnosed with cervical Cervical intraepithelial neoplasia, or malignancy by histopathological examination

  2. Detection of chronic cervicitis incidence

    Time frame: 1 year

    Detection of number of cases diagnosed with inflammatory cells and other markers of inflammation

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Acronym: HSTH

Important dates

Study start
2017
Primary completion
2020
Study completion
2021
First posted
Mar 22, 2021
Registry last updated
Apr 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.